High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients

doi:10.12998/wjcc.v6.i4.44

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

(381)

(410)

(0)

(20)

(2)

(7149)

(11)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Clin Cases. Apr 16, 2018; 6(4): 44-53
Published online Apr 16, 2018. doi: 10.12998/wjcc.v6.i4.44

Table 2 Univariate analysis¹n (%)

	TBA > 8	TBA < 8	P value
	(n = 80)	(n = 1190)	P value
TBA (mean ± SD, μmol/L)	14.66 ± 1.24	3.07 ± 0.06	6.15 × 10^-144
Alkaline phosphatase (mean ± SD, U/L)	81 ± 5.81	69.3 ± 1.25	0.021
Albumin (mean ± SD, g/L)	38.0 ± 0.92	39.9 ± 0.21	0.017
Vitamin D	25 (31)	254 (21)	0.038
Vitamin E	2 (3)	9 (1)	0.103
Calcium	30 (38)	336 (28)	0.076
Prednisone	16 (20)	160 (13)	0.100
Azathioprine	37 (46)	383 (32)	0.009
Smokers	12 (15)	330 (28)	0.012
Thrombosis	4 (5)	17 (1)	0.015

¹Results expressed in number with percentage in parenthesis otherwise stated. Univariate analysis of factors differentiating patients with or without cholestasis. TBA: Total bile acid; SD: Standard deviation.

Full Size Table

Citation: Girardin M, Hadengue A, Frossard JL, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J Clin Cases 2018; 6(4): 44-53
URL: https://www.wjgnet.com/2307-8960/full/v6/i4/44.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i4.44

Girardin M, Hadengue A, Frossard JL, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J Clin Cases 2018; 6(4): 44-53 [PMID: 29670889 DOI: 10.12998/wjcc.v6.i4.44]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.